ClinicalTrials.gov
public full text
Public Domain
CONTAIN COVID-19: Convalescent Plasma to Limit COVID-19 Complications in Hospitalized Patients
This is a randomized, blinded phase 2 trial that will assess the efficacy and safety of anti-SARS-CoV-2 convalescent plasma in hospitalized patients with acute respiratory symptoms requiring oxygen supplementation.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Convalescent Plasma for the Treatment of Severe SARS-CoV-2 (COVID-19)#828255
- Transfusion of Convalescent Plasma for the Early Treatment of Patients With COVID-19#834381
- Anti-SARS Cov-2 T Cell Infusions for COVID 19#968207
- Expanded Access to Convalescent Plasma for Treatment of COVID-19#992706
- Observational Cohort of COVID-19 Patients at Raymond-Poincare#804306
Record · ID 861950
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive